目前全球融合蛋白疗法代表企业包括Novartis, Abbvie, Merck, Takeda, AstraZeneca, Amgen, UCB, Aboslute Antibody, Biogen, Origene, Prospec, Chimerigen, J & J, Abnova, Bristol-Myers Squibb, Roche, Peprotech, Eli Lilly and ...